when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

SANDOZ · news · pharmadog

← back to SANDOZ

News mentioning SANDOZ

19 stories

Sep 9, 26STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and morestat

Sep 9, 26Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar visionbiospace

Sep 8, 26Sandoz unveils plan for biosimilar expansion and new $300M factory in Sloveniaendpoints

Aug 18, 26AstraZeneca scores in lung cancer; Sandoz inks a China dealbiopharma dive

Aug 18, 26Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilarsbiospace

Aug 17, 26STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and morestat

Aug 11, 26Austria’s new growth fund could further bolster its dynamic biotech innovation economybiospace

Aug 5, 26STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and morestat

Aug 4, 26STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and morestat

Aug 4, 26STAT+: The latest orphan drug exemptions may not be warranted, analysis findsstat

Aug 3, 26STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate casestat

Aug 3, 26Michigan reports the first 2 U.S. deaths related to a diarrhea-causing parasitestat

Aug 3, 26STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra paymentsstat

Aug 3, 26Curium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing caseendpoints

Aug 3, 26STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and morestat

Aug 3, 26STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with statesstat

Jul 22, 26Trump threatens tariffs on imported generic drugsbiopharma dive

Jul 2, 26Sandoz launches direct-to-consumer platform with growth disorder drugendpoints

Jun 4, 26Parabilis Medicines charts $413M IPO to back peptide pipelineendpoints